Hitachi Chemical Advanced Therapeutics

The completed acquisition allows Hitachi Chemical to fully leverage PCT’s extensive experience in cell therapy development and manufacturing technology, wide-ranging manufacturing locations, robust sales network and other resources to expand and strengthen PCT’s services in the United States and add services in Japan, Europe and other regions.

As a part of Hitachi Chemical, we will be able to expand manufacturing capacity, capabilities and service offerings to more effectively and efficiently meet the needs of our clients anywhere in the world. With the backing of Hitachi Chemical, we look forward to establishing a global network of facilities for cell therapy development and manufacturing in which we will integrate the expertise, experience and technologies of our combined organization.